Other News To Note
Wednesday, November 14, 2012
Can-Fite BioPharma Ltd., of Petach, Israel, said it designated CF603, an A3 adenosine receptor allosteric modulator licensed from Leiden University, to be developed for the treatment of sexual dysfunction. Recent studies showed that adenosine functions to relax the corpus cavernosum and promote penile erection.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.